AKER BIOMARINE ASA financials
AKER BIOMARINE ASA
549300V34T6VWDSYWE64 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | $199.0M | $196.3M |
| Cost of sales | $129.9M | $123.8M |
| Gross profit | $69.1M | $72.4M |
| Other income | $2.0M | -$100.0K |
| Operating profit (EBIT) | -$6.5M | -$10.4M |
| Finance costs | $10.9M | $19.7M |
| Profit before tax | -$14.5M | -$32.3M |
| Income tax expense | -$100.0K | $0 |
| Profit for the year | $180.3M | -$9.0M |
| Total comprehensive income | $180.3M | -$4.4M |
| Cash flow statement | ||
| Net cash from operating activities | $12.2M | $47.4M |
| Net cash from investing activities | $379.4M | -$48.9M |
| Purchase of PP&E (capex) | $17.4M | $45.9M |
| Purchase of intangibles | $5.7M | $3.4M |
| Net cash from financing activities | -$404.0M | $6.7M |
| Dividends paid | $373.2M | $0 |
| Balance sheet | ||
| Total assets | $387.4M | $827.1M |
| Non-current assets | $185.7M | $537.0M |
| Property, plant & equipment | $49.0M | $341.5M |
| Right-of-use assets | $2.6M | $9.1M |
| Intangible assets & goodwill | $123.4M | $155.4M |
| Current assets | $201.8M | $290.2M |
| Inventories | $96.3M | $183.7M |
| Trade & other receivables | $54.2M | $71.5M |
| Cash & equivalents | $15.0M | $27.5M |
| Total equity | $173.9M | $366.5M |
| Non-current liabilities | $160.3M | $347.7M |
| Long-term borrowings | $140.3M | $344.0M |
| Current liabilities | $53.2M | $112.9M |
| Short-term borrowings | $7.2M | $49.0M |
| Trade & other payables | $42.6M | $63.9M |
| Deferred tax liabilities | $8.3M | $3.7M |
| Derived metrics | ||
| Free cash flow | -$5.2M | $1.5M |
| Operating margin | -3.3% | -5.3% |
| Net margin | 90.6% | -4.6% |
| Return on equity | 103.7% | -2.5% |
| Cash conversion ratio | 0.07× | -5.27× |
| Capex coverage | 0.70× | 1.03× |
| Other reported items | ||
| Additional Paidin Capital | $494.0M | $493.8M |
| Adjustments For Depreciation and Amortisation Expense | $47.8M | $52.3M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | -$209.0M | $500.0K |
| Adjustments For Income Tax Expense | -$100.0K | -$25.0M |
| Adjustments For Interest Expense | $24.9M | $31.0M |
| Adjustments For Undistributed Profits of Associates | $0 | -$3.0M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -$7.1M | $0 |
| Amount Removed From Reserve of Cash Flow Hedges and Included In Initial Cost Or Other Carrying Amount of Nonfinancial Asset Liability Or Firm Commitment For Which Fair Value Hedge Accounting Is Applied | $8.2M | — |
| Basic Earnings Loss Per Share From Continuing Operations | $-0.16 | $-0.36 |
| Basic Earnings Loss Per Share From Discontinued Operations | $2.23 | $0.26 |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | $700.0K | $0 |
| Deferred Tax Assets | $5.7M | $25.0M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | $16.6M | $16.3M |
| Diluted Earnings Loss Per Share From Continuing Operations | $-0.16 | $-0.36 |
| Diluted Earnings Loss Per Share From Discontinued Operations | $2.23 | $0.26 |
| Equity and Liabilities | $387.4M | $827.1M |
| Finance Income | $4.0M | $1.5M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | -$1.0M | -$800.0K |
| Income Taxes Paid Refund Classified As Operating Activities | $0 | $700.0K |
| Increase Decrease In Cash and Cash Equivalents | -$12.5M | $5.2M |
| Increase Decrease Through Other Contributions By Owners | -$373.1M | — |
| Increase Decrease Through Transactions With Owners | — | $100.0K |
| Increase Decrease Through Transfers and Other Changes Equity | -$8.2M | — |
| Interest Paid Classified As Operating Activities | $24.3M | $29.7M |
| Interest Received Classified As Operating Activities | $4.4M | $2.2M |
| Investment Accounted For Using Equity Method | $400.0K | $100.0K |
| Issue of Equity | — | $100.0K |
| Issued Capital | $75.9M | $75.9M |
| Liabilities | $213.6M | $460.6M |
| Noncurrent Contract Assets | $1.2M | $3.2M |
| Noncurrent Derivative Financial Liabilities | $11.8M | $0 |
| Other Comprehensive Income | $0 | $4.6M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | $0 | $4.7M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | $0 | -$100.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | $0 | $4.7M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | $0 | -$100.0K |
| Other Receivables | $900.0K | $300.0K |
| Proceeds From Noncurrent Borrowings | $150.7M | $40.0M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | $404.1M | $600.0K |
| Profit Loss From Continuing Operations | -$14.4M | -$32.3M |
| Profit Loss From Discontinued Operations | $194.6M | $23.3M |
| Retained Earnings | -$396.3M | -$203.3M |
| Selling General and Administrative Expense | $61.0M | $66.4M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | $0 | -$3.0M |
| Weighted Average Shares | 87.7M | 87.7M |
Every line item above is a fact tagged in AKER BIOMARINE ASA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.